 B. Study Eligibility Criteria to Initiate Treatment for Secondary Registration Participants must meet the following criteria to be eligible to proceed to receive vaccine treatment on the study labstestsassessments within 7 days prior to secondary study registration and within 14 days of first vaccine administration unless otherwise specified 